Raynaud's disease
Get the facts on Raynaud’s and symptoms
Find out more
We are here for you.
Whether you are newly diagnosed or have been living with Scleroderma and Raynaud's for years, we can help. SRUK are the only UK charity providing support and information and funding research into Scleroderma and Raynaud's.
SRUK is dedicated to improving the lives of people with scleroderma and Raynaud's phenomenon
Our mission is to improve the lives of everyone affected by scleroderma and Raynaud's. We do this by investing in research, improving awareness and understanding of the conditions and providing information and support to all those affected.
Run for SRUK
Whether you are ready for the Royal Parks Virtual half marathon in April or want to wait for actual runs later in the year. We have a range of events that will motivate you and keep you on that roadmap to your fitness goals!
Receive our Newsletter to keep up-to-date with the latest news and developments
Make a Donation to SRUK
Help support the life-changing work of Scleroderma and Raynaud's UK and support people with the conditions
SRUK latest news
See all newsFriday 16th April 2021
A Design for Life: is scleroderma in the genes?
What is the link between our genetic code and developing scleroderma? Researchers from Spain have recently studied genetic alterations and established a connection with the pathways that dictate the clinical features of scleroderma. The study is significant because increasing our understanding of the genetic pathway could be a faster route towards identifying effective new therapies for this complex condition.
Thursday 1st April 2021
Open Research - revolutionising the publishing process for SRUK research
SRUK is working with our partners at the Association of Medical Research Charities via their new Open Research Platform, to revolutionise the publishing process for our researchers. This will enable SRUK-funded research groups to publish their work in a streamlined and cost-effective way, with the ultimate goal of translating new knowledge into effective treatments for people living with scleroderma.
Friday 19th March 2021
What's the outcome? Measuring the effectiveness of new treatments in clinical trials
Clinical trials are the only way to ensure that new treatments are effective. But how exactly does the process work? FInd out why 'outcome measures’ and ‘endpoints’ are crucial, and how SRUK funding is playing a key role in improving the measures used in treatments for scleroderma.
Give us your website feedback
Help us make our website best suit the needs of our community